Abstract:Background: Airway bacterial microbiota influences the prognosis in children with respiratory syncytial virus infection. The study aimed to investigate the effect of the airway-dominant bacterial microbiota on disease severity in children with pneumonia of respiratory syncytial virus infection. Methods: A retrospective study was conducted in the Children’s Hospital of Chongqing Medical University, which involved a cohort of patients with respiratory syncytial virus (RSV)-infected pneumonia from January 2012 to December 2021. Patients were assigned to a normal flora group or to a dominant flora group (with the top 5 individual bacteria) based on the nasopharyngeal aspirates culture and matched using propensity-score matching. Univariate analysis and multivariate analysis were performed to estimate the risk factors of poor prognosis in dominant flora. Results: Five thousand five hundred and twelve patients in the normal flora and 4556 in the dominant flora were included ( Escherichia coli 514, Streptococcus pneumoniae 1516, Staphylococcus aureus 506, Moraxella catarrhalis 509 and Haemophilus influenzae 1516, respectively). The dominant flora had more patients developing severe pneumonia, needing mechanical ventilation/tracheal intubation (up to 15.8% in the S. aureus ) and admission to the intensive care unit (up to 4.5% in the E. coli ) than in the normal flora (28.5% vs. 25.9%; P = 0.001; 9.8% vs. 5.4%; P < 0.001; 2.0% vs. 1.2%; P <0.001). And the hospitalization was longer in the dominant flora than in the normal flora [8 (6–9) vs. 8 (7–9) days; P < 0.001], the E. coli and S. aureus had the longest hospitalization [8 (7–10) days]. Several factors were associated with critical illness in Dominant flora according to multivariate analysis ( P < 0.001), including age (OR: 0.965; CI: 0.954–0.976; P < 0.001), anhelation (OR: 0.530; CI: 0.446–0.631; P < 0.001), disorders of consciousness (OR: 0.055; CI: 0.016–0.185; P < 0.001) as well as assisted respiration (OR: 0.115; CI: 0.097–0.138; P 10 mg/L (OR: 0.686; CI: 0.560–0.839; P < 0.001), SpO 2 <90% (OR: 0.366; CI: 0.214–0.628; P < 0.001), pulmonary consolidation (OR: 0.511; CI: 0.364–0.717; P < 0.001) and pulmonary atelectasis (OR: 0.362; CI: 0.236–0.555; P < 0.001). Conclusions: The airway-dominant bacterial microbiota influenced disease severity and comorbidities in children with RSV-infected pneumonia. Clinicians should pay attention to the nasopharyngeal aspirate culture, especially after detecting S. aureus and E. coli in RSV-infected children with pneumonia, closely observe the disease progression and take timely measures to avoid adverse outcomes.

The Prognosis in Children With Pneumonia of Respiratory Syncytial Virus Co-detection With Airway Dominant Flora

Epidemiological Characteristics and Immune Status of Children with Respiratory Syncytial Virus.

Clinical Significance of Nasopharyngeal Bacterial Colonization in Children with Acute Bronchiolitis

Clinical characteristics and nasopharyngeal bacteria profiles in children with respiratory syncytial virus bronchiolitis

Gut and respiratory tract microbiota in children younger than 12 months hospitalized for bronchiolitis compared with healthy children: can we predict the severity and medium-term respiratory outcome?

Co-infection Analysis of Common Respiratory Pathogens in Children with Pneumonia in a Hospital of Dongyang City, Zhejiang Province

RSV pneumonia with or without bacterial co-infection among healthy children

THE CLINICAL CHARACTERISTICS AND PREDICTORS OF REFRACTORY MYCOPLASMA PNEUMONIAE PNEUMONIA IN CHILDREN

Epidemiological Trend of RSV Infection Before and During COVID-19 Pandemic: A Three-Year Consecutive Study in China

Neutrophil Activation and Protease Imbalance in Respiratory Tract of Infants with Respiratory Syncytial Virus Bronchiolitis

Epidemiology of respiratory syncytial virus in hospitalized children with community-acquired pneumonia in Guangzhou: a 10-year study

Impact of Bacteria in Nasal Aspirates on Disease Severity of Bronchiolitis

Altered intestinal microbiota in children with bronchiolitis

Microbiology and prognostic factors of hospital- and community-acquired aspiration pneumonia in respiratory intensive care unit.

Role Of Preceding Viral Or Mycoplasma Pneumoniae Infection In Invasive Bacterial Diseases In Chinese Children

Retrospective Analysis of Clinic and Epidemiology of Respiratory Syncytial Virus Pneumonia in 309 Neonates

Viral and Bacterial Co-Infection in Hospitalised Children with Refractory Mycoplasma Pneumoniae Pneumonia

Clinical Characteristics and Risk Factors of Severe Respiratory Syncytial Virus-Associated Acute Lower Respiratory Tract Infections in Hospitalized Infants

Characteristics of the oropharyngeal microbiota among infants with pneumonia and their effects on immune response and subsequent respiratory morbidity

Pulmonary function changes in infants with respiratory syncytial virus or mycoplasma pneumoniae infection and clinical significance

Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia